Evidence map›Paper›PMID 35904143›Full record

ArticleJournal of diabetes science and technology2022

Hospital Diabetes Meeting 2022.

Jingtong Huang, Andrea M Yeung, Kevin T Nguyen, Nicole Y Xu, Jean-Charles Preiser, Robert J Rushakoff, Jane Jeffrie Seley, Guillermo E Umpierrez, Amisha Wallia, Andjela T Drincic and 11 more

Abstract read
In one paragraph

Article in Journal of diabetes science and technology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Jingtong HuangDiabetes Technology Society, Burlingame, CA, USA.ORCID 0000-0002-3119-9361
Andrea M YeungDiabetes Technology Society, Burlingame, CA, USA.ORCID 0000-0002-5592-453X
Kevin T NguyenDiabetes Technology Society, Burlingame, CA, USA.ORCID 0000-0001-9102-6537
Nicole Y XuDiabetes Technology Society, Burlingame, CA, USA.ORCID 0000-0001-9353-8819
Jean-Charles PreiserErasme University Hospital, Brussels, Belgium.ORCID 0000-0003-3163-0390
Robert J RushakoffUniversity of California San Francisco, San Francisco, CA, USA.ORCID 0000-0001-7502-9092
Jane Jeffrie SeleyWeill Cornell Medicine, New York, NY, USA.ORCID 0000-0003-1582-4320
Guillermo E UmpierrezEmory University, Atlanta, GA, USA.ORCID 0000-0002-3252-5026
Amisha WalliaNorthwestern University Feinberg School of Medicine, Chicago, IL, USA.ORCID 0000-0002-3183-4062
Andjela T DrincicUniversity of Nebraska Medical Center, Omaha, NE, USA.ORCID 0000-0001-8365-7662
Roma GianchandaniCedars-Sinai Health Systems, Los Angeles, CA, USA.ORCID 0000-0002-3791-5891
M Cecilia LansangCleveland Clinic, Cleveland, OH, USA.ORCID 0000-0002-7364-5550
Umesh MasharaniUniversity of California San Francisco, San Francisco, CA, USA.ORCID 0000-0002-3269-804X
Nestoras MathioudakisJohns Hopkins University, Baltimore, MD, USA.ORCID 0000-0002-0210-655X
Francisco J PasquelEmory University, Atlanta, GA, USA.ORCID 0000-0002-3845-6703
Signe SchmidtSteno Diabetes Center Copenhagen, Gentofte, Denmark.ORCID 0000-0002-6968-6675
Viral N ShahBarbara Davis Center for Diabetes, University of Colorado, Aurora, CO, USA.ORCID 0000-0002-3827-7107
Elias K SpanakisUniversity of Maryland, Baltimore, MD, USA.ORCID 0000-0002-9352-7172
Andreas StuhrDiabetes Technology Society, Burlingame, CA, USA.ORCID 0000-0002-8087-2436
Gerlies M TreiberMedical University of Graz, Graz, Austria.ORCID 0000-0002-1658-5280
David C KlonoffDiabetes Research Institute, Mills-Peninsula Medical Center, San Mateo, CA, USA.ORCID 0000-0001-6394-6862

Funding

Continuous Glucose Monitoring in Insulin Treated Hospitalized Veterans with DM2 at Higher Risk for HypoglycemiaI01CX001825 · VA · BALTIMORE VA MEDICAL CENTER · PI SPANAKIS, ILIAS · 2018 to 2023
–
CSRD VA I01 CX001825
6 · The paper itself

Abstract

The annual Virtual Hospital Diabetes Meeting was hosted by Diabetes Technology Society on April 1 and April 2, 2022. This meeting brought together experts in diabetes technology to discuss various new developments in the field of managing diabetes in hospitalized patients. Meeting topics included (1) digital health and the hospital, (2) blood glucose targets, (3) software for inpatient diabetes, (4) surgery, (5) transitions, (6) coronavirus disease and diabetes in the hospital, (7) drugs for diabetes, (8) continuous glucose monitoring, (9) quality improvement, (10) diabetes care and educatinon, and (11) uniting people, process, and technology to achieve optimal glycemic management. This meeting covered new technology that will enable better care of people with diabetes if they are hospitalized.

Indexed as

Coronavirus InfectionsDiabetes MellitusDiabetes Mellitus, Type 1Blood GlucoseBlood Glucose Self-MonitoringHospitalsHumansBlood Glucosecontinuous glucose monitordiabeteselectronic health recordhospitalinsulintechnology

Identifiers

PMID35904143
PMCPMC9445340

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.